Well-planned waiting spaces

Well-planned waiting spaces

Lobbies must be designed with much of the seating oriented perpendicular to the exterior view and the reception area, enabling patients to maintain visibility to the check-in area

By Manu Malhotra

Healthcare experiences are made up of more than moments of care—they also include the time spent in transition between those moments. One of the first spaces patients and families encounter, the waiting room is traditionally considered a necessary element in every hospital and medical facility, yet it rarely drives the planning process and seldom is subjected to a rigorous review. These transitional spaces where patients and their families wait are often uncomfortable and unappealing, increasing feelings of stress and negative mind sets.
Beside typically following codes and/or guidelines to determine the number of seats per whatever unit of the area it serves, and then trying to accommodate these particular physical needs of the population who will use it, we also need to see and understand waiting spaces from patient point of view which is often irritating, stressful, full of nervousness, anxiety and unease mainly caused by overcrowded nature of the space with little privacy, too much noise, lack of sightlines to information sources, minimal support for personal devices, uncomfortable and unappealing environments with few positive

Create inviting spaces that reduce stress
Create inviting spaces that reduce stress We have been designing comfortable settings and hosting amenities by incorporating soothing materials, textures, colours, lighting, and views, along with a space for items such as bags, personal devices or beverage. It is important to understand and take care of people’s preferences for varying levels of noise and other stimuli, and create quiet zones where people can retreat from sources of noise as well as conversation areas where families can be together without any negative distraction. The lobbies must be designed with much of the seating oriented perpendicular to the exterior view and the reception area, enabling patients to maintain visibility to the check-in area, while also enjoying the views of nature.
One must critically analyse and select the style, material, and colour of the furniture to reflect the healthcare practice brand. Art galleries should be planned within the waiting spaces to display the artwork of local people and school kids and space for hanging community bulletin board should be incorporated that includes flyers about local hikes, flea markets, and other activities.

Provide for productive transitions
In order to design ideal waiting spaces one must understand its character as waiting spaces in a healthcare facility vary with departments such as – OPD waiting, IP waiting, ICU waiting & OP/ surgery waiting. While designing a healthcare facility, one must design a range of waiting spaces appropriate for varying activities, durations, organisational needs and to provide the required levels of privacy. Besides varying waiting types need to cater to varying age groups as well.
The seatings are planned with clear sightlines to doorways, clinician entrances, and information desks. One must critically analyse the duration and select modular and flexible furniture which allows for changing design and configuration and support the activities and postures appropriate for the duration of the wait.
ICU Waiting: ‘Vigil’ saps families not only of their energy but also their ability to make intelligent decisions, therefore ICU waiting shall be designed in order to allow the users to cope up with the experience. One should create a user-friendly comfortable and calming environment for the family within the maximum possible proximity to patients to easy access and at the same time give enough privacy to doctors and staff so that they are not disturbed. Apart from comfortable recliners one must provide additional spaces such as lockers for the personal belongings of family, blanket issue area, prayer area to provide spiritual support as well as a lounge area to provide social support and provision of café for overnight stays.
OP/ Surgery waiting area: Even routine surgeries can take several hours. For families, this waiting space is being designed with a variety of activities such as workstations, lockers for storing and retrieving personal items, social settings, consultation cum counseling rooms/ bays with the surgeon located just outside the surgery corridor for sharing visual information.

Make waiting active – Integrating different age groups
Patients often miss work for their appointments and helping them be productive can alleviate stress and reflect that the organisation value their time. Therefore beside providing free WiFi, one must make provision for individual desks or work tables and charging stations in the design. Also, one must design a variety of seating options such as – a cluster of chairs around a coffee table, a quiet space for professionals, and a child-friendly corner to keep kids entertained without bothering others. With 600 million people, nearly half of population under the age of 25, India is a country with maximum youth percentage and in order to cater the needs for the millennial, the waiting spaces are designed to facilitate working on laptops and do con calls in enclosed cubicles.
Organisations are measured and reimbursed on how well they deliver the patient experience. In an effort to increase their scores, many organisations are not only focusing on renovation or redesign of patient rooms or clinical spaces but on transition spaces as well. This has led the healthcare planners to rethink on waiting spaces in order to design to its maximum efficiency. By providing more choices and supporting a range of postures and activities, we are redesigning waiting spaces as adaptable and productive environments that provide better healthcare experiences.

The Blockchain Disruption

The Blockchain Disruption

How the technology can revolutionise healthcare by ensuring greater transparency and enhanced data security

By Team HR

The world is in the midst of a revolutionary technology: Blockchain. Invented by Satoshi Nakamoto in 2008 to serve as the public transaction ledger of the cryptocurrency bitcoin, today blockchain technology has VCs investing over $1.4bn in the technology in the past three years. The World Economic Forum estimates 10% of the global GDP is to be stored using blockchain by 2027.
In simple words, blockchain technology is a technology that creates immutable and distributable data records which are shared peer to peer between networked database systems. Blockchain relies on established cryptographic techniques to allow each participant in a network to interact without preexisting trust between the parties. The financial and healthcare sectors are expected to greatly benefit from blockchain. The banks that use this technology save $8–12 billion annually, point out reports.
In healthcare, blockchain can be leveraged to revamp the sector and make it more cost effective, ensure data security and reduce cost. A paper “Blockchain: Opportunities for health care” by Deloitte Consulting LLP, describes blockchain as a new model for health information exchanges. This technology could provide new models for healthcare business.
Says Dr Harish Pillai, CEO – Aster Hospitals & Clinics, India, Aster DM Healthcare, “Till date, 40% of healthcare data is unrecorded or are filled with error that misleads the information, whereby blockchain will help you to solve all these issues to un-scattered patient crucial data, streamline overall managerial process, provide easy access to information, remove outdated system with the latest technology. Some of the key advantages of block chain in healthcare are:
Data security: Blockchain ensures security of patient data. Says Mohua Sengupta, EVP & Global Head of Services, 3i Infotech, “While no technology is 100% secure, blockchain is definitely more secure than the other technologies we use today. Blockchain prevents unauthorised individuals from accessing patients’ confidential data.”
Patient updated data: With blockchain technology, patients are able to upload their data and store it securely for future use without being worried about data security or without having to overwrite the earlier data, since all data is time stamped in blockchain.

Mohua Sengupta, EVP & Global Head of Services, 3i Infotech

Sharing data and provide consent to share: In the world of connected healthcare, patients can easily provide their consent to share personal data with various stakeholders as they deem fit, and sharing across nodes is also easy.
Says Dr KM Cherian, Chairman and CEO, Frontier Lifeline Hospital, “Each member in the blockchain network has a secret key and a public key cryptographically linked with each identifier. The private key would enable each member to unlock the details relevant to them. Important information is exchanged between different systems in health sector, the current system meets failure often when it has to handle the data efficiently and to provide the required data to clinicians and patients when they demand.”
Direct billing: The blockchain system enables the corresponding accounts and finance department to do direct billing and secured money transactions without the involvement of any third party.
Claim processing simplified: Claim processing involves multiple parties, including third parties, and hence clearing a claim securely takes time. With blockchain technology, multiple stakeholders can be connected as separate and secured nodes, making approvals and validations easier and hence claim processing is faster and simpler.
Sharing public health data even across borders: “Today when the world is struggling to address the cross-border movement of communicable diseases, blockchain comes as a much-needed solution to address the matter securely, without having to compromise patients’ confidentiality,” says Sengupta.
Drug traceability: During the launch of a blockchain-based 360-degree ecosystem for healthcare, Ritu Tyagi, Head of Global Marketing, Healthureum, said, “Drug traceability is a major issue and we believe blockchain technology will keep a track of every stage of supply chain system and easy drug traceability.” With the help of blockchain, it will be easier to track the transaction nodes between the key participants like drug manufacturers, wholesalers, pharmacists, medical representatives- thus securing the product information, combating the problem of counterfeit drugs, thus contributing to overall drug traceability on the smooth road.
In the long term, a nationwide blockchain network for electronic medical records may improve efficiencies and support better health outcomes for patients.

However, there are various factors influencing the slow adoption of block chain in healthcare.
Major cultural shift – “Although the healthcare sector is slowly getting digitised, healthcare companies still rely on paperwork for many processes. Therefore, it would be difficult for the companies

Dr K M Cherian, Chairman and CEO, Frontier Lifeline Hospital

to shift to electronic health records on a short notice. For any industry, altering consumer’s behaviour and changing their routine functions is challenging,” says Dr Pillai.
Healthcare is distributed – At present, insurance payers and healthcare providers are not in sync when it comes to handling records. Therefore, it would be very difficult for them to adopt blockchain technology.
Unwillingness to disclose data- There are several cases where the hospitals are not willing to share their exact cost data with insurance companies. “The prime reason for this is insurance companies charge different rates for different patients,” says Dr Pillai.
Only when multiple organisations use it: “It is not just in healthcare, like any new path breaking technology, blockchain is taking its time to be centre of any business. Also, using blockchain technology is advantageous only when there are multiple organisations on the blockchain. This is making the adoption of blockchain even slower. Unlike most new technologies that ensure a first mover’s advantage, blockchain doesn’t,” says Sengupta.
It is only when multiple stakeholders are on a blockchain or on related blockchain, even from different sectors, that the advantages of blockchain technology can be unlocked. For instance, if we take claims processing as a use case, then maximum benefit can be unlocked only when multiple hospitals, health insurance companies, banks, TPAs are all on the blockchain and talking. And it’s a challenge for multiple organisations to take the leap at the same time.
“We expect to see more active participation from the regulators and the Government into the blockchain space to define regulations and provide some impetus for organisations to jump on to blockchain bandwagon,” says Sengupta.
According to Hyperledger’s survey, 42.9% of healthcare organisations suppose that the interoperability of electronic health records will help for faster blockchain implementation; with 28.6% of respondents ready to use this technology in care settings today. There will be increasingly more opportunity to deploy blockchain applications in healthcare. “However, there are also merits to centralisation, including speed, privacy, and more. Knowing when to opt for centralisation vs. decentralisation will be the key,” says Dr Pillai.

Healthcare Times YouTube Channel for Hospitals


Healthcare Times YouTube Channel

The only dedicated Healthcare YouTube Channel promoting the best Hospital brands in India

In Association with

Identity Space – Healthcare Media Agency &

Healthcare Radius, leading B2B healthcare magazine


About:  Healthcare Times is an upcoming YouTube channel featuring leading Indian hospital brands and clinics offering wide choices of treatments for individuals seeking medical help. Healthcare Times You Tube channel promotes India as a top medical destination for domestic and international patient in particular. The channel broadcasts eminent leaders in healthcare, their future vision and growth plans, How modern technology is transforming medical treatment in India, Latest trends in healthcare and wellness, Presenting breakthrough medical cases successfully executed  by skilled Indian doctors and much more

Partner:  Content brought in collaboration with Healthcare Radius, India’s leading premier B2B healthcare media by ITP Publishing India

Target audience: Healthcare professionals, Patients [domestics & international], Medical Operators, Facilitators, Health bodies, Accreditation Agencies, Embassies, Insurance Companies, Corporates, Education Institute, Medical Colleges

Promotions: Video links of Healthcare Radius Blog, Usage of social media platforms like Facebook,Twitter & Linkedin and other relevant  partner platforms

Video length & Hosting duration: Video length – 15-20 mins , Hosting duration timeline is sole discretion of Healthcare Times

Cost Implication: Nominal min production & editing cost to be borne at actual.


For inquires contact:whatsapp-image-2017-02-09-at-1-45-56-pmIdentity Space | M- 98215 11115 | Email: info@identityspace.in

Six Month Clinical Trial Data Shows First Thin Strut Fully Dissolvable Stent in the World, Developed in India, to be Safe

Six Month Clinical Trial Data Shows First Thin Strut Fully Dissolvable Stent in the World, Developed in India, to be Safe

Findings of the six month clinical trial on the first thin strut fully dissolvable stent in the world, developed in India, were unveiled at the prestigious main arena, Late Breaking Clinical Trials/First Report Investigations at the Cardiovascular Therapeutics (TCT) 2016, Washington DC, on Monday, October 31, at 12:30 pm EST. The TCT is the biggest and best regarded meeting of interventional cardiologists in the world. This was a proud moment for India, as the data was presented by the eminent interventional cardiologist Dr Ashok Seth, Chairman Fortis Escorts Heart Institute, who was the principal investigator of the study.

The study titled MeRes-1 is the first-in-man study of the novel thin-strut PLLA-based sirolimus-eluting bioresorbable vascular stent (MeRes100). It considered Six-Month Clinical, Angiographic, Intravascular ultrasound (IVUS), and Optical coherence tomography (OCT) results in patients with Coronary Artery Disease.


Presenting the findings of the study, Dr. Ashok Seth, MBBS, FRCP,  DSc, Chairman of the Fortis Escorts Heart Institute and Chairman of the Cardiology Council, Fortis Group of Hospitals in New Delhi, India, said, “This is a big day for India and the ‘Make in India’ program.  It also reveals to the world that our Indian device industry has the ability to be innovative, creative and support high quality research. The innovative design of the MeRes100 scaffold developed in India addresses some of the limitations of currently available Bio Resorbable Stents (dissolvable stents) and may have higher success and lower complication rates in the long term.  It would also cost much lesser than the currently available dissolvable stents and therefore give more benefit to higher number of patients.  The MeRes-1, first-in-man study demonstrates that this new generation thinner strut sirolimus eluting BRS is both safe and effective at six months. These encouraging results provide the basis for further studies using wider range of length and sizes in more complex and larger patient population.”

The MeRes100 is a low profile 100µm thin strut PLLA based BRS with a unique hybrid design featuring open cells at the center and closed cells at the edges resulting in improved track-ability and access to side branches. It also has enhanced visibility with three circumferential radio opaque markers at each end.

In this prospective, multicenter, single arm trial of MeRes100 BRS, a total of 108 patients (116 lesions) were enrolled at 16 Indian sites from May 2015 to April 2016. The primary end-point was Major Adverse Cardiac Events (MACE), a composite of cardiac death, myocardial infarction, Ischaemia Driven Target Lesion Revascularization (ID-TLR), and Ischaemia Driven Target Vessel Revascularization (ID-TVR) at six months. The secondary end-point was scaffold thrombosis at six months.  The study found no MACE or stent thrombosis (ST) after the deployment of the scaffold up to six month follow-up. Quantitative Coronary Analysis (QCA) data at six months demonstrated very favorable in scaffold late lumen loss of 0.15±0.26mm. Intravascular ultrasound (IVUS) and Optical coherence tomography (OCT) analysis showed no scaffold recoil and near complete strut coverage (99.3%) with neointima.

The TCT is the annual scientific symposium of the Cardiovascular Research Foundation (CRF) featuring a number of first report investigations on novel stents that could become the next generation of bioresorbable stents in patients.

“Bioresorbable stents (dissolvable stents) have the potential to be greatly impactful in the treatment of coronary artery disease, and it is exciting to see these first report investigations of several new and novel stents advancing the technology forward,” said Ajay Kirtane, MD, SM, and a Co-Director of TCT. He is also Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian Hospital/Columbia University Medical Center and an Associate Professor of Medicine at Columbia University College of Physicians and Surgeons. “These results give us the first insights into their safety and efficacy, but larger randomized trials are necessary in order to establish their role in clinical practice.”

Roche Diagnostics raises the bar on blood screening in the Middle East

Roche Diagnostics raises the bar on blood screening in the Middle East

Today at the 34th International Conference of ISBT in Dubai, United Arab Emirates, Roche Diagnostics introduced powerful blood safety innovations.  These cutting-edge solutions will further enable blood banks in the Middle East and around the world with high-sensitivity blood screening solutions needed to secure blood supplies.  With the aid of these tools, the risk of contaminated blood is significantly reduced. Moreover, patients in need will be provided with safe transfusions as a result of the reduction in manual steps.  The comprehensive portfolio of advanced serology screening and Nucleic Acid Testing (NAT) technologies, delivers industry-leading reliability and workflow efficiency for blood centres, bringing peace of mind to both physicians and patients. 

 Every year, over 108 million blood donations are made worldwide. This transfusion of blood and blood products help save millions of lives yet infectious diseases pose a significant threat on public health; thus, making reliability an unshakable necessity. Reaffirming Roche’s commitment to the highest levels of quality in the Middle East, the Blood Safety Solution by Roche not only brings this reliability to blood banks but also full traceability, excellent cross-contamination controls and less downtime.  The efficiency of laboratories is extended to the fullest when such benefits are advanced from state-of-the-art technologies like Electrochemiluminescence (ELC) and Polymerase Chain Reaction (PCR); resulting in high specificity and NAT real-time-target-discrimination.

 Commenting on this year’s active participation at the International Society for Blood Transfusion, Harald Wolf, General Manager – Roche Diagnostics Middle East, said: “ISBT is a great launchpad to present our Blood Safety Solutions as securing safe blood supplies has become an increasingly important element in healthcare.  We are proud to bring our innovations to the UAE and the Middle East as it delivers reliability and workflow efficiency to blood centres; bringing peace of mind to both patients and physicians in the region. ”

 Renowned worldwide for being first movers and adopters in many fields, the United Arab Emirates has always been at the forefront of securing safe blood supplies by taking significant strides in equipping its blood donation centres across the country with the latest diagnostic technologies available.  Thus, ISBT which is taking place in the UAE for the first time sets the perfect stage to display these innovations locally, regionally and to the world alike.

Advantage India

India’s medical tourism market is expected to grow exponentially, becoming an attractive destination for medical tourists by offering cost-effective quality healthcare

By Dalip Kumar ChopraMTH-2

As healthcare is becoming costlier in developed countries around the globe, India plays an important role in providing quality healthcare at a low cost. India’s medical tourism market is expected to grow from present $3 billion to around $8 billion by 2020. According to the CII – Grant Thornton white paper, cost is a major driver for nearly 80% of medical tourists across the globe.

The cost factor and accredited facilities in Singapore, Thailand, India, Malaysia, Taiwan, Mexico and Costa Rica makes them a destination of choice for the medical tourists. Bangladesh and Afghanistan dominate the Indian Medical Value Travel (MVT) with 34% share. Africa, GCC & CIS Regions (whose current share is just 30%) present the maximum possible opportunity for the Indian healthcare sector. Medical tourists from these sectors currently favour the South East Asian medical corridors. Chennai, Mumbai, Andhra Pradesh and NCR are the most favoured medical tourism destinations for the medical tourists in India. India, one of world’s fastest growing markets for medical tourism, is becoming more popular among Russians seeking better and cheaper options for treatment which is either not available in Russia or requires a long wait. Asian countries are seriously challenging Europe, US and Israel as attractive destinations for medical tourists: people who travel across international borders to obtain healthcare. India, Thailand and Singapore are three countries in Asia that receive the maximum number of medical tourists, because of the quality of healthcare infrastructure and the availability of highly skilled doctors, as well as lower cost of treatment.

Growth Potential
India hosts thousands of medical tourists from the US, Canada, Australia and the UK, as well as from African Countries and Asian neighbours like Bangladesh, Sri Lanka and China yearly. According to ASSOCHAM, in 2011 India saw 850,000 medical tourists and by the end of 2015 this number may rise to 3.2 million. The Indian medical tourism market is expected to expand at a CAGR of 27% to reach $3.9 billion in 2014, from $1.9 billion in 2011, according to the “Medical Value Travel” in India report by KPMG and FICCI. Globally, the medical value travel industry is estimated at $10.5 billion and is expected to grow to $32.5 billion over the next five years at CAGR of 17.9%.

Comparison with Russia
Despite Russia being known in India particularly for the quality of its medical education – consider that eight out of ten Indian students in Russia are enrolled in medicine or dentistry courses – there are multiple factors that make Russian patients seek better healthcare options abroad and more recently, in India too.

The Indian healthcare sector amounted for $78.6 billion in 2012 and is expected to reach approximately $158.2 billion by 2017, according to KPMG. The Russian healthcare sector in the same period, according to PWC, stood at $86 billion. The difference between the two countries is that while in India the healthcare industry has, since 1990s, emerged as a huge segment with dynamic private sector involvement, in Russia it has been dominated by only the government for about 100 years. Today more than 60% of the Russian healthcare market belongs to the government sector, although the share of private healthcare is growing rapidly.

Russian industry analysts stress that, despite Russian doctors being highly qualified, they are not enough, thus leaving smaller regional medical centres poorly staffed and equipped. Misdiagnosis and delayed diagnosis and medical errors are common in the Russian healthcare system as bureaucratic hurdles abound and long queues of people wait for prescribed treatment and quotas for free treatment. Patients, especially children and elderly people, are often considered non–responsive to treatment and are thus denied medical services. Outside Russia, they get medical help in most cases.
India has all the possible ingredients to be an attractive medical tourism destination viz.

  • World renowned Indian doctors ( specialists and super specialists ).
  • Highly skilled nurses and paramedics.
  • World class hospitals with state–of–the-art infrastructure and medical equipment.
  • No language barrier. English being the preferred language used in all hospitals of India. Besides that, there is availability of language interpreters in all Indian hospitals.
  • Excellent Indian hospitality.
  • Low medical treatment cost.
  • Low pre and post treatment and stay cost.


Dilip Kumar Chopra is the Director with Gurdasmal Hospitality& Consultancy Services Pvt Ltd, Noida

The Birthplace – Superior Clinical Care


The Birthplace is the ultimate destination for every mother-to-beMTHlogo

The Birthplace is a unique facility at Hyderabad that addresses the entire spectrum of women’s health issues spanning from PCOS, endometriosis, infertility and other conditions, to pregnancy, reconstructive surgeries and more. Being a 25-bed boutique facility, it allows the hospital to focus all its time and attention into providing the very best care, making it all as warm and personal as possible.

Apart from providing superior clinical care for almost every health concern that women face, the Birthplace is also the ultimate destination for every mother-to-be. The teams provide personalised family-centred care, which means partnering with patients to tailor to their experience, specific to their needs. Their approach is reflected across our services including fertility and preconception, prenatal diagnostics, foetal and pregnancy health, obstetric care, labour and delivery, maternity, neonatology, comfort techniques for labour and developmental paediatrics.

At Birthplace, there’s always someone to make sure that everything is executed to perfection. A stunning lobby, exquisite rooms, high-end entertainment systems, Wi-Fi connectivity, a super-comfortable
to pamper patients, luxurious shower cabinets and germ resistant carpeting add a dash of luxury and comfort.

The patients gain access to world-class clinical expertise with a designated executive to cater to their every whim. The hospital conducts regular sessions like yoga and lamaze, and offer a range of delivery options, including water births. The doctors also advise patients on how they can still consider a normal birth, even if they have had a C-section in the past. All this at a package price that holds no unpleasant surprises at check-out.

At service is the most advanced 4D ultrasound machine in the world, high-tech operation suites and an industry-best NICU facility, complemented by a world-class team of obstetricians, nurses and counsellors.

The hospital offers the following specialties:

  • Fertility and Gynaecology.
  • High Risk Obstetrics and Neonatology.
  • Cosmetic and Reconstructive Surgeries.
  • Weight Loss Surgeries / Metabolic Surgeries.
  • Urology, General and Minimal Access Surgeries.

For International Patients
The Birthplace is a hospital that can cater to the needs of patients from across the world within its top-notch boutique facility. The company extends a warm welcome to international guests, along with an assurance that they can expect a lot more than great healthcare solutions here.

  • Birthplace offers a range of treatments and will help patients with all the information they need before they decide to make the trip to India.
  • Patients are assigned a single point of contact, once they connect with the Birthplace, who will assist them in everything from scheduling doctors’ appointments to currency conversions.
  • The staff is attentive and sensitive to the patient’s every need. Right from picking them up from the airport and checking them into a luxurious hotel the Birthplace, to hassle-free consultation and discharge.
  • The Birthplace help patients with formalities like getting their permits / VISA processed, and plan their entire stay beforehand.
  • The clinical infrastructure consists of some of the best equipment in the world, including world-class operation theatres, monitoring systems, a 4D ultrasound and an advanced NICU.
  • The doctors, technicians, nurses and other staff are qualified, well-trained and among the best in the industry, not to mention extremely warm and approachable.

Be a Guest Blogger

bloggerWelcome Guest BloggerThank you for responding to our mailer,now you can be a guest blogger at Healthcare Radius Blog. This is an open invitation to pen articles and your thoughts on healthcare system in our country, it can be new trends, health policies, management, medical technologies or just your views on recent happenings in Healthcare industry. This is a b2b blog hence all readers are  from core healthcare sector, please note that all post will be moderated by our editor and will be published after scrutinizing the content. Request you to provide the details in the form below.We will soon get back to with as we get your request. Thank you

[contact-form][contact-field label=’Name’ type=’name’ required=’1’/][contact-field label=’Hospital / Organisation Name’ type=’text’ required=’1’/][contact-field label=’Designation’ type=’text’ required=’1’/][contact-field label=’Mobile No’ type=’text’ required=’1’/][contact-field label=’Email’ type=’email’ required=’1’/][contact-field label=’I wish to blog on topic like’ type=’text’ required=’1’/][/contact-form]

Healthcare IT – Invitation for contributory articles

Health-IT_NewsDear Contributor,

Healthcare Radius is India’s premier healthcare magazine, recently we have been getting good reviews and feedback from our readers on Health IT articles currently published. We would like to collaborate with expert health IT professionals in delivering more valuable health IT content to readers. Thank you for coming to this page, if you are keen to contribute Health IT articles please provide details below. We will reach  you soon.

Looking forward to your interesting contributions for Healthcare Radius.

[contact-form][contact-field label=’Person Name’ type=’text’ required=’1’/][contact-field label=’Company Name’ type=’text’ required=’1’/][contact-field label=’Designation’ type=’text’/][contact-field label=’Mobile No’ type=’text’ required=’1’/][contact-field label=’Email’ type=’email’ required=’1’/][contact-field label=’City’ type=’text’ required=’1’/][contact-field label=’Website’ type=’url’ required=’1’/][contact-field label=’I like to contribute articles on:’ type=’textarea’ required=’1’/][/contact-form]


Dr V Mohan, Chairman & Chief of Diabetology – Focus on Research

Dr V Mohan, Chairman & Chief of Diabetology, Dr Mohan’s Diabetes Specialities Centre, talks about the unique services offered by his groupMTHlogo


Within a span of 25 years, Dr Mohan’s DSC has blossomed into an international centre of excellence. What has been the key to your institute’s success?
I have been working in the field of diabetes, since my undergraduate days. I was lucky to be mentored by my fath
er, late Professor M Viswanathan, considered as the ‘Father of Diabetology’ in India. This early start and the first 20 years that I spent with my father at his institute, the MV Hospital for Diabetes, helped us to develop Dr Mohan’s Diabetes Specialities Centre into a world class institute. We established this centre in 1991 and subsequently the centre has grown to have its presence in many parts of India and even abroad.

Please tell us about the USP of Dr Mohan’s DSC. What are the unique services that you offer?
We offer ‘total diabetes care’ i.e. offer all diabetes specialities under one roof. This is a concept which we evolved in the early 1980s and have perfected over the years. Moreover, we have a very strong research base through our sister institution, ‘The Madras Diabetes Research Foundation’. We are always innovating in the space of diabetes therapy, prevention and in etiology of diabetes. This always keeps us ahead and helps us to innovate because we believe that ‘Today’s research is tomorrow’s treatment’.

Share with us about the initiatives taken by your speciality centre to build Dr Mohan’s DSC brand identity in the healthcare industry.
From the beginning, we have insisted that we will maintain ‘world class quality’. We were the first to introduce Electronic Medical Records. Today , we have 3,70,000 patients in our diabetes electronic records which by far is the largest in the world. We were also the first to introduce several new innovations in the country. For instance, we were the first to set up a separate eye unit for diabetic retinopathy and many other innovations. Recently, we have set up our genetics division and through this, we are able to accurately genotype our patients which helps in providing personalised treatment to our patients. All these have helped to build Dr Mohan’s brand in the healthcare industry.

Your centre has been doing phenomenal service to the Indian community. How have you poised yourself to treat patients beyond borders? What special services do you offer for international patients?
We have already started a centre in Muscat, Oman which is doing well. We hope to take the same world class services that we offer in India to our international patients as well and expand to other countries.

Do you see any challenges treating international patients? How do you manage the treatment modality?
I don’t see any special challenges in treating international patients. We do get patients from Muscat, Dubai, Saudi Arabia, Qatar, Sri Lanka, Malaysia, Singapore, Nigeria, Tanzania, Kenya, South Africa and even from the UK, the US and Canada who come to us for our specialised treatment. After the initial treatment at our centre at our main headquarters in Gopalapuram, we do offer email consultations for sometime till they come back to our centre for their review.

Can you highlight some diabetes disease profile that is prevalent with international patients. How different is the disease profile compared to our disease profile?
Many of the patients who come from abroad are overweight or frankly obese and hence insulin resistance is an added problem with these patients. Moreover, many of the patients only come when they develop complications like foot complications. A common scenario is that when a doctor advises an amputation, they rush to our centre – hoping we can save the foot. If we create greater awareness, we can get patients to come at earlier stages, thereby offer even better treatment to them.

What steps are required to be taken by healthcare entities to propel the growth of
for our country?

There is a lot of potential for medical tourism because India offers world class care at an affordable rate.
However, a lot of marketing and creation of awareness is needed.

Can you share your future vision for Dr Mohan’s DSC.
Till now, we have been mainly focused on Chennai, Tamil Nadu and Hyderabad. In the near future, we hope to become a pan-India brand and also spread our wings to several countries in the Middle East and Africa.